ATP6V1E2

gene
On this page

Also known as MGC9341VMA4ATP6E1

Summary

ATP6V1E2 (ATPase H+ transporting V1 subunit E2, HGNC:18125) is a protein-coding gene on chromosome 2p21, encoding V-type proton ATPase subunit E 2 (Q96A05). Subunit of the V1 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons.

Predicted to enable proton-transporting ATPase activity, rotational mechanism. Predicted to be involved in regulation of macroautophagy. Predicted to act upstream of or within proton transmembrane transport. Predicted to be located in cytosol. Predicted to be part of proton-transporting two-sector ATPase complex, catalytic domain.

Source: NCBI Gene 90423 — RefSeq curated summary.

At a glance

  • GWAS associations: 10
  • Clinical variants (ClinVar): 48 total
  • MANE Select transcript: NM_001318063

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18125
Approved symbolATP6V1E2
NameATPase H+ transporting V1 subunit E2
Location2p21
Locus typegene with protein product
StatusApproved
AliasesMGC9341, VMA4, ATP6E1
Ensembl geneENSG00000250565
Ensembl biotypeprotein_coding
OMIM617385
Entrez90423

Gene structure

Transcript identifiers

Ensembl transcripts: 22 — 18 protein_coding, 4 protein_coding_CDS_not_defined

ENST00000306448, ENST00000505245, ENST00000522219, ENST00000522587, ENST00000524188, ENST00000524249, ENST00000890126, ENST00000890127, ENST00000890128, ENST00000890129, ENST00000890130, ENST00000890131, ENST00000890132, ENST00000890133, ENST00000923418, ENST00000923419, ENST00000923420, ENST00000923421, ENST00000965787, ENST00000965788, ENST00000965789, ENST00000965790

RefSeq mRNA: 4 — MANE Select: NM_001318063 NM_001318063, NM_001371281, NM_001371282, NM_001371283

CCDS: CCDS1826

Canonical transcript exons

ENST00000522587 — 5 exons

ExonStartEnd
ENSE000011692524651184746512812
ENSE000020793144653661146536703
ENSE000020930484653581346535927
ENSE000020975594654139046541453
ENSE000021354984654221746542577

Expression profiles

Bgee: expression breadth ubiquitous, 204 present calls, max score 95.88.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.3611 / max 62.2497, expressed in 1243 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
281882.25721226
281860.05343
281870.05059

Top tissues by expression

232 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001995.88gold quality
right testisUBERON:000453488.25gold quality
left testisUBERON:000453388.17gold quality
testisUBERON:000047386.67gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099184.95gold quality
islet of LangerhansUBERON:000000684.08gold quality
leukocyteCL:000073881.66gold quality
monocyteCL:000057681.64gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047380.96gold quality
adult organismUBERON:000702380.49gold quality
C1 segment of cervical spinal cordUBERON:000646980.33gold quality
hindlimb stylopod muscleUBERON:000425279.48gold quality
muscle of legUBERON:000138379.45gold quality
granulocyteCL:000009479.42gold quality
ventricular zoneUBERON:000305379.25gold quality
gastrocnemiusUBERON:000138879.20gold quality
pancreasUBERON:000126477.92gold quality
right frontal lobeUBERON:000281077.56gold quality
anterior cingulate cortexUBERON:000983577.51gold quality
right adrenal glandUBERON:000123377.41gold quality
spinal cordUBERON:000224077.33gold quality
right adrenal gland cortexUBERON:003582777.23gold quality
prefrontal cortexUBERON:000045177.20gold quality
putamenUBERON:000187477.09gold quality
amygdalaUBERON:000187676.83gold quality
caudate nucleusUBERON:000187376.81gold quality
left adrenal glandUBERON:000123476.76gold quality
nucleus accumbensUBERON:000188276.72gold quality
left adrenal gland cortexUBERON:003582576.44gold quality
calcaneal tendonUBERON:000370176.31gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.57

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 1)

  • Rat vacuolar H(+)ATPase associates with NHE-RF (Na(+)/H(+) exchanger regulatory factor); the E subunit was co-immunoprecipitated from rat kidney cytosol with NHE-RF antibodies. (PMID:10748165)

Cross-species orthologs

6 orthologs

OrganismSymbolGene ID
danio_rerioatp6v1e1aENSDARG00000014085
danio_rerioatp6v1e1bENSDARG00000030694
mus_musculusAtp6v1e2ENSMUSG00000053375
rattus_norvegicusAtp6v1e2ENSRNOG00000015566
drosophila_melanogasterVha26FBGN0283535
caenorhabditis_elegansWBGENE00006917

Paralogs (1): ATP6V1E1 (ENSG00000131100)

Protein

Protein identifiers

V-type proton ATPase subunit E 2Q96A05 (reviewed: Q96A05)

Alternative names: Vacuolar proton pump subunit E 2

All UniProt accessions (2): Q96A05, A0A140VKA8

UniProt curated annotations — full annotation on UniProt →

Function. Subunit of the V1 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons. V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment.

Subunit / interactions. V-ATPase is a heteromultimeric enzyme made up of two complexes: the ATP-hydrolytic V1 complex and the proton translocation V0 complex. The V1 complex consists of three catalytic AB heterodimers that form a heterohexamer, three peripheral stalks each consisting of EG heterodimers, one central rotor including subunits D and F, and the regulatory subunits C and H. The proton translocation complex V0 consists of the proton transport subunit a, a ring of proteolipid subunits c9c’’, rotary subunit d, subunits e and f, and the accessory subunits ATP6AP1/Ac45 and ATP6AP2/PRR.

Tissue specificity. Testis specific.

Similarity. Belongs to the V-ATPase E subunit family.

RefSeq proteins (4): NP_001304992, NP_001358210, NP_001358211, NP_001358212 (=MANE)

Domains & families (InterPro)

IDNameType
IPR002842ATPase_V1_EsuFamily
IPR038495ATPase_E_CHomologous_superfamily

Pfam: PF01991

UniProt features (1 total): chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96A05-F193.070.86

Function

Pathways and Gene Ontology

Reactome pathways

5 pathways

IDPathway
R-HSA-1222556ROS and RNS production in phagocytes
R-HSA-77387Insulin receptor recycling
R-HSA-917977Transferrin endocytosis and recycling
R-HSA-9639288Amino acids regulate mTORC1
R-HSA-983712Ion channel transport

MSigDB gene sets: 85 (showing top): REACTOME_SIGNALING_BY_INSULIN_RECEPTOR, GOBP_REGULATION_OF_AUTOPHAGY, REACTOME_INNATE_IMMUNE_SYSTEM, GOCC_SECRETORY_GRANULE, CAGCTG_AP4_Q5, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_MACROAUTOPHAGY, GOBP_REGULATION_OF_CATABOLIC_PROCESS, HP1SITEFACTOR_Q6, WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN, GOMF_PROTON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, WEBER_METHYLATED_LCP_IN_SPERM_UP, GOBP_TRANSMEMBRANE_TRANSPORT, KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION, CP2_01

GO Biological Process (3): regulation of macroautophagy (GO:0016241), monoatomic ion transport (GO:0006811), proton transmembrane transport (GO:1902600)

GO Molecular Function (2): proton-transporting ATPase activity, rotational mechanism (GO:0046961), protein binding (GO:0005515)

GO Cellular Component (3): acrosomal vesicle (GO:0001669), cytosol (GO:0005829), proton-transporting two-sector ATPase complex, catalytic domain (GO:0033178)

Reactome top-level categories

Rollup of top-5 pathways:

CategoryPathways
Innate Immune System1
Signaling by Insulin receptor1
Iron uptake and transport1
Cellular response to starvation1
Transport of small molecules1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of autophagy1
macroautophagy1
transport1
monoatomic cation transmembrane transport1
proton transmembrane transporter activity1
ATPase-coupled monoatomic cation transmembrane transporter activity1
ATPase activity, coupled to transmembrane movement of ions, rotational mechanism1
binding1
secretory granule1
cytoplasm1
cellular anatomical structure1
proton-transporting two-sector ATPase complex1
membrane protein complex1

Protein interactions and networks

STRING

938 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ATP6V1E2ATP6V1G3Q96LB4886
ATP6V1E2ATP6V1G2O95670875
ATP6V1E2ATP6V1G1O75348875
ATP6V1E2ATP6V1B1P15313863
ATP6V1E2ATP6V1B2P21281863
ATP6V1E2ATP6V1C2Q8NEY4851
ATP6V1E2ATP6V1DQ9Y5K8842
ATP6V1E2ATP6V1C1P21283832
ATP6V1E2ATP6V1HQ9UI12832
ATP6V1E2ATP6V0D1P12953824
ATP6V1E2ATP6V0A2Q9Y487810
ATP6V1E2ATP6V0A1Q93050796
ATP6V1E2ATP6V0A4Q9HBG4795
ATP6V1E2ATP6V1FQ16864794
ATP6V1E2ATP6V0D2Q8N8Y2790

IntAct

40 interactions, top by confidence:

ABTypeScore
ATP6V1G1ATP6V1E2psi-mi:“MI:0915”(physical association)0.830
ATP6V1E2ATP6V1G1psi-mi:“MI:0915”(physical association)0.830
ATP6V1G2ATP6V1E2psi-mi:“MI:0915”(physical association)0.670
ATP6V1C2ATP6V1G1psi-mi:“MI:0914”(association)0.640
ATP6V1E2BBLNpsi-mi:“MI:0915”(physical association)0.560
BBLNATP6V1E2psi-mi:“MI:0915”(physical association)0.560
RASSF10ATP6V1E2psi-mi:“MI:0915”(physical association)0.560
MESDATP6V1E2psi-mi:“MI:0915”(physical association)0.560
ATP6V0A1ATP6V1G1psi-mi:“MI:0914”(association)0.530
ATP6V0A4ATP6AP2psi-mi:“MI:0914”(association)0.530
ATP6V1B2ATP6V1G1psi-mi:“MI:0914”(association)0.530
ATP6V1G2ATP6V1B1psi-mi:“MI:0914”(association)0.530
MAPTNCANpsi-mi:“MI:0914”(association)0.350
ATP6V1C2POTEFpsi-mi:“MI:0914”(association)0.350
ATP6V1B1ATP6V1G1psi-mi:“MI:0914”(association)0.350
ATP6AP2A2Mpsi-mi:“MI:0914”(association)0.350
ATP6V0A2ATP6V1G1psi-mi:“MI:0914”(association)0.350
ATP6V1HATP6V1B1psi-mi:“MI:0914”(association)0.350
SMPD2A2ML1psi-mi:“MI:0914”(association)0.350
ATP6V1G1ATP6V1E2psi-mi:“MI:0915”(physical association)0.000
ATP6V1G2ATP6V1E2psi-mi:“MI:0915”(physical association)0.000

BioGRID (31): ATP6V1E2 (Two-hybrid), ATP6V1E2 (Two-hybrid), ATP6V1E2 (Affinity Capture-MS), ATP6V1E2 (Affinity Capture-MS), ATP6V1E2 (Two-hybrid), ATP6V1G1 (Two-hybrid), ATP6V1E2 (Affinity Capture-MS), ATP6V1E2 (Affinity Capture-MS), ATP6V1E2 (Two-hybrid), ATP6V1E2 (Two-hybrid), ATP6V1E2 (Two-hybrid), ATP6V1E2 (Two-hybrid), ATP6V1E2 (Affinity Capture-MS), ATP6V1E2 (Proximity Label-MS), ATP6V1E2 (Affinity Capture-MS)

ESM2 similar proteins: A1CQI3, A3KNK7, B0WAM5, B0WG73, B2RYZ5, B3MQ24, B3NUB6, B4H2S0, B4IK33, B4JLC3, B4L1Z8, B4M6M6, B4NUB3, B4PY93, B5XC71, B5XGH3, P45437, Q08DS5, Q17MZ8, Q1DRC2, Q1HQY6, Q1JQD4, Q29IN4, Q2F5R8, Q32LB7, Q3KPT5, Q3UQ44, Q498D9, Q4H3N8, Q5BDL9, Q5M759, Q5RC82, Q68EW7, Q6DH42, Q6NQ54, Q6NQH4, Q6P255, Q7QIL8, Q803N9, Q8TF65

Diamond homologs: O00780, O13687, O23948, O94072, P0CAN7, P11019, P22203, P31402, P36543, P50518, P54611, Q01278, Q32LB7, Q39258, Q40272, Q41396, Q4R761, Q6PCU2, Q95X44, Q96A05, Q9C9Z8, Q9D593, Q9MB46, Q9SWE7, Q9U1G5, O27039, Q3J9F2, O06501, Q5JDS0, Q9UXU4, A6UT32, C6A5F1

SIGNOR signaling

1 interactions.

AEffectBMechanism
ATP6V1E2“form complex”V-ATPasebinding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 19 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Insulin receptor recycling9244.7×1e-19
Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy5239.9×9e-11
Transferrin endocytosis and recycling9236.8×1e-19
ROS and RNS production in phagocytes9215.9×2e-19
Amino acids regulate mTORC1685.9×3e-10
Ion channel transport961.7×3e-14

GO biological processes:

GO termPartnersFoldFDR
synaptic vesicle lumen acidification7344.9×3e-15
vacuolar acidification7269.9×1e-14
regulation of macroautophagy8124.5×3e-14
proton transmembrane transport7115.0×3e-12

Disease & clinical

Clinical variants and AI predictions

ClinVar

48 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance45
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

247 predictions. Top by Δscore:

VariantEffectΔscore
2:46512820:A:Tacceptor_gain1.0000
2:46543185:GCAG:Gdonor_gain1.0000
2:46543187:AGGT:Adonor_loss1.0000
2:46543189:G:GGdonor_gain1.0000
2:46543189:GTA:Gdonor_loss1.0000
2:46512819:CAG:Cacceptor_gain0.9900
2:46543184:CGCAG:Cdonor_gain0.9900
2:46543185:GCAGG:Gdonor_gain0.9900
2:46543186:CAG:Cdonor_gain0.9900
2:46543187:AG:Adonor_gain0.9900
2:46543188:GG:Gdonor_gain0.9900
2:46543190:T:Gdonor_loss0.9900
2:46512808:CTCAG:Cacceptor_gain0.9700
2:46512810:CAG:Cacceptor_gain0.9700
2:46512812:GC:Gacceptor_loss0.9700
2:46512813:C:CAacceptor_loss0.9700
2:46512813:C:CCacceptor_gain0.9700
2:46512821:G:GCacceptor_gain0.9700
2:46512833:A:Cacceptor_gain0.9700
2:46512814:T:Aacceptor_loss0.9600
2:46512818:CCAG:Cacceptor_gain0.9600
2:46512821:G:Cacceptor_gain0.9600
2:46512827:A:Tacceptor_gain0.9600
2:46512826:C:CTacceptor_gain0.9500
2:46512815:A:Cacceptor_gain0.9400
2:46519779:C:CTdonor_gain0.9300
2:46519780:T:TTdonor_gain0.9300
2:46512809:TCAG:Tacceptor_gain0.9200
2:46512810:CAGC:Cacceptor_gain0.9200
2:46512819:C:CTacceptor_loss0.9200

AlphaMissense

1487 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:46512658:G:CF18L0.996
2:46512658:G:TF18L0.996
2:46512660:A:GF18L0.996
2:46512645:C:GA23P0.992
2:46512612:C:GA34P0.989
2:46512598:A:CF38L0.984
2:46512598:A:TF38L0.984
2:46512600:A:GF38L0.984
2:46512563:C:GR50P0.983
2:46512633:C:GA27P0.978
2:46512618:C:GA32P0.975
2:46512477:C:GA79P0.973
2:46512578:A:GL45P0.972
2:46512581:C:GR44P0.961
2:46512116:C:GR199P0.960
2:46512663:C:GA17P0.958
2:46512667:C:AM15I0.958
2:46512667:C:GM15I0.958
2:46512667:C:TM15I0.958
2:46512586:T:AK42N0.956
2:46512586:T:GK42N0.956
2:46512659:A:CF18C0.952
2:46512077:C:GR212P0.950
2:46512659:A:GF18S0.946
2:46512495:A:GS73P0.945
2:46512130:A:CN194K0.944
2:46512130:A:TN194K0.944
2:46512113:A:GL200P0.940
2:46512345:C:GG123R0.939
2:46512308:C:GR135P0.938

dbSNP variants (sampled 300 via entrez): RS1000118632 (2:46511785 C>T), RS1000162926 (2:46532866 C>G), RS1000378538 (2:46531624 A>G), RS1000486971 (2:46537646 G>C), RS1000506497 (2:46525319 G>A), RS1000572358 (2:46526588 T>C), RS1000639419 (2:46533063 A>C,T), RS1000660005 (2:46530437 C>A), RS1000693159 (2:46538739 T>C), RS1000744851 (2:46539034 C>T), RS1000773624 (2:46536550 G>A,C), RS1000837922 (2:46537977 GA>G,GAA), RS1000878723 (2:46522166 T>C), RS1000928138 (2:46541689 G>A), RS1000944557 (2:46518431 G>A,T)

Disease associations

OMIM: gene MIM:617385 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

10 associations (top):

StudyTraitp-value
GCST005025_31Anti-saccade response8.000000e-06
GCST005027_2Anti-saccade error rate in psychotic disorders2.000000e-07
GCST010002_390Refractive error1.000000e-11
GCST010697_51Cortical surface area (min-P)4.000000e-12
GCST010698_64Subcortical volume (min-P)3.000000e-09
GCST010699_93Brain morphology (min-P)1.000000e-12
GCST010700_22Cortical thickness (MOSTest)9.000000e-11
GCST010701_108Cortical surface area (MOSTest)4.000000e-12
GCST010702_134Subcortical volume (MOSTest)2.000000e-14
GCST010703_146Brain morphology (MOSTest)5.000000e-08

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0006874antisaccade response measurement
EFO:0004346neuroimaging measurement
EFO:0004840cortical thickness

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — V-type ATPase

CTD chemical–gene interactions

22 total (human), top 22 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cisplatinaffects expression, decreases expression2
Valproic Acidaffects expression, decreases expression2
triphenyl phosphateaffects expression1
bisphenol Aaffects cotreatment, increases methylation1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
sodium arsenitedecreases expression1
ferrous chloridedecreases expression1
beta-methylcholineaffects expression1
CGP 52608affects binding, increases reaction1
ICG 001increases expression1
2,3,5-trichloro-6-phenyl-(1,4)benzoquinoneincreases expression1
Decitabineaffects expression1
Fulvestrantaffects cotreatment, increases methylation1
Arsenicaffects methylation1
Atrazinedecreases expression1
Benzo(a)pyreneincreases methylation1
Phenobarbitalaffects expression1
Quercetinincreases expression1
Rotenoneincreases expression1
Tretinoindecreases expression1
Cyclosporineincreases expression1
Copper Sulfateincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.